Clinical outcomes after treatment initiation demonstrated that starting treatment decreased the duration and number of angioedema attacks, thus potentially supporting the use of preventative treatments such as pd-C1-INH and tranexamic acid for angioedema attacks in patients with HAE nC1-INH and AE-UNK. The gene discussed is SERPING1; the disease is hereditary angioedema.